New Pfizer data makes case for booster shots 6 months after primary doses
(WASHINGTON) — The Food and Drug Administration on Wednesday released new data from Pfizer's submitted application to approve booster doses of its Covid-19 vaccine. In it, Pfizer demonstrates what it sees as proof that third shot will be both safe and necessary for most... Read More.